Treatment of cancer with immunostimulatory HIV Tat derivative polypeptides

Details for Australian Patent Application No. 2010230073 (hide)

Owner NaniRX, Inc.

Inventors Cohen, David I.

Agent Pizzeys

Pub. Number AU-A-2010230073

PCT Pub. Number WO2010/111292

Priority 61/310,221 03.03.10 US; 61/306,278 19.02.10 US; 61/162,605 23.03.09 US

Filing date 23 March 2010

Wipo publication date 30 September 2010

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

29 September 2011 PCT application entered the National Phase

  PCT publication WO2010/111292 Priority application(s): WO2010/111292

19 January 2012 Alteration of Name

  The name of the applicant has been altered to NaniRX Therapeutics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010230074-Battery life estimation

2010230069-Spray process for selective oxidation